Muhammad Muhammad

Dr. Muhammad Muhammad


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in Currents in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
MMMuhammad Muhammad
Muhammad Muhammad
SNSadaf Niazi
Sadaf Niazi
FFFarwa Fayyaz
Farwa Fayyaz
AZAyesha Zahoor
Ayesha Zahoor
TZTehzeeb Zehra
Tehzeeb Zehra
HAHafiz Muhammad Usman Abid
Hafiz Muhammad Usman Abid
The current review focuses on the biological role and potential benefits of rutin, a natural flavonoid, in medical and pharmaceutical fields, especially for the treatment of different disorders in human beings. Rutin is present in various fruits and vegetables, such as tobacco, forsythia, buckwheat viola, apricots, cherries, grapefruit, plum, oranges, Japanese pagoda tree, eucalyptus macrorhyncha, St. John’s Wort, ginkgo, apples, and hydrangea as vitamin P. Its absorption is constrained by the gut flora, thus it is less bioavailable. However, in consolidation with other drugs, rutin shows enhanced properties such as anti-inflammatory, antioxidant, antimicrobial, cardioprotective, neuroprotective, and anticancer properties. Literature provides little data about its activity in cosmetics as antiaging, as well as its use in ulcerative colitis, autism, animal food, and pregnancy. Although several studies have revealed its activity against SARS-CoV-2. For this study, literature search was performed using various tools including books, Google Scholar, PubMed, and SpringerLink. A total of 370 research papers were studied. It was observed that 35% were about anticancer, 20% were about antioxidant, 15% were about anti-inflammatory activity of rutin, while 10% each were about antihypertensive, antimicrobial, and neuroprotective effects of rutin.

10 January 2024 in Biological and Clinical Sciences Research Journal
Verified
Journal Article
Open access
PDF file
MMMuhammad Muhammad
Muhammad Muhammad
HKHaa Kharl
Haa Kharl
SNS Niazi
S Niazi
NAN Ameer
N Ameer
FFF Fayyaz
F Fayyaz
MAM Aftab
M Aftab
Apigenin (4′, 5, 7,-trihydroxyflavone), a natural glycoside belonging to a class of cyclone, is found in many different forms in plants and vegetables such as grapefruits, parsley, onions, oranges, tea, chamomile, wheat, sprouts, oregano, artichokes and in some seasonings. It effectively treats various anti-inflammatory disorders because it is less toxic, non-mutagenic, and potent against skeletal muscle sarcoplasmic reticulum. Furthermore in combination with allopathic drugs, its activity was enhanced as an anti-inflammatory, antioxidant, cardioprotective, neuroprotective, and anticancer agent. Little data was found that emphasized its role as an anti- hypoglycemic and sedative agent; however, it was found to promote hair growth by inhibiting the TGF-B1 pathway. Different characterization techniques were used to determine physicochemical properties, and various formulations of apigenin with other polymers have been done to enhance its biological role. The literature search used various scholarly search engines (Google Scholar, PubMed, Springer Link, etc.). A total of 355 research articles were reviewed, and it was observed that 34% of articles were about anti-inflammatory, 15% of articles were about neuroprotective, and 10% of studies were about anti-cancer use of apigenin. Thus, the current review focuses on its activity, characterization and limitations of apigenin role.

31 October 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NANabeela Ameer
Nabeela Ameer
MHMuhammad Hanif
Muhammad Hanif
GAGhulam Abbas
Ghulam Abbas
MMMuhammad Muhammad
Muhammad Muhammad
KMKhalid Mahmood
Khalid Mahmood
Baher DaihomBaher Daihom
Baher Daihom
Background: The lack of local availability for drugs in the colon can be addressed by preparing a self-microemulsifying drug delivery system (SMEDDS) of curcumin (Cur) which is ultimately used for the treatment of inflammatory bowel disease (IBD). Methods: From preformulation studies, Lauroglycol FCC (oil), Tween 80 (surfactant), Transcutol HP (co-surfactant), and Avicel (solid carrier) were selected for the preparation of blank liquid and solid Cur-loaded SMEDDSs (S-Cur-SMEDDSs). Results: Z-average size (12.36 ± 0.04 nm), zeta potential (−14.7 ± 0.08 mV), and polydispersity index (PDI) (0.155 ± 0.036) showed a comparative droplet surface area and charge of both SMEDDSs. The physicochemical stability of Cur in S-Cur-SMEDDSs was confirmed via FTIR, DSC, TGA, and XRD analyses, while morphological analysis through SEM and atomic force microscopy (AFM) confirmed Cur loading into SMEDDSs with an increased surface roughness root mean square (RMS) of 11.433 ± 0.91 nm, greater than the blank SMEDDS. Acute toxicity studies with an organ weight ratio and % hemolysis of 15.65 ± 1.32% at a high concentration of 600 mM showed that S-Cur-SMEDDSs are safe at a medium dose (0.2–0.8 g/kg/day). The excellent in vitro antioxidant (68.54 ± 1.42%) and anti-inflammatory properties (56.47 ± 1.17%) of S-Cur-SMEDDS proved its therapeutic efficacy for IBD. Finally, S-Cur-SMEDDS significantly improved acetic acid-induced IBD in albino rats through a reduction in the disease activity index (DAI) and macroscopic ulcer score (MUS) from 4.15 ± 0.21 to 1.62 ± 0.12 at 15 mg/kg/day dose, as confirmed via histopathological assay. Conclusions: Based on the above findings, S-Cur-SMEDDS appears to be a stable, less toxic, and more efficacious alternative for Cur delivery with strong competence in treating IBD.